← Back to Patent Explorer
US4009079A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for quantitatively determining glucoamylase in human urine and body fluids

Assignee: Ono Pharmaceutical Co Ltd
•
Filing: 1976-01-26
•
Granted: 1977-02-22
•
Expires: 1996-01-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for quantitatively determining glucoamylase in human urine and body fluids which comprises removing low molecular weight substances from a human urine or body fluid sample, adding to the resulting sample which is free of low molecular weight (from about 500 to about 20,000) substances maltotriitol, phenyl- alpha -glucoside or 2,4-dinitrophenyl- alpha -glucoside, which are specific substrates for glucoamylase, and quantitatively determining the glucose, phenol or 2,4-dinitrophenol which is a degradation product of the above substrates, respectively.

Inventors

  • 👤 Kazuaki Tsujino
  • 👤 Junnosuke Kida
  • 👤 Masanobu Hosotani
  • 👤 Noshi Minamiura
  • 👤 Takehiko Yamamoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 15:30
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/34; C12Q1/40; C12Q2334/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 75 words
A method for determining the amount of glucoamylase in human urine and body fluids which comprises removing low molecular weight substances having a molecular weight of from about 500 to about 20,000 from a human urine or body fluid sample, adding to the resulting sample which is free of low molecular weight substances maltotriitol which is a specific substrate of glucoamylase, and measuring the amount of glucose, which is the degradation product of the substrate.
Claim 2
Independent Claim 75 words
A method for determining the amount of glucoamylase in human urine and body fluids which comprises removing low molecular weight substances having a molecular weight of from about 500 to about 20,000 from a human urine or body fluid sample, adding to the resulting sample which is free of low molecular weight substances maltotriitol which is a specific substrate of glucoamylase, and measuring the amount of glucose, which is the degradation product of the substrate.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-02-22 1980-08-23 1981-02-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-02-22 1984-08-23 1985-02-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-02-22 1988-08-23 1989-02-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag